Right to Optimal Hormonal Levels

Hormones regulate virtually every aspect of human functioning: metabolism, mood, energy, reproduction, growth, stress response, body composition, and cognitive function. A hormonal imbalance can have profound consequences on quality of life and overall health — yet hormonal medicine remains one of the most underdiagnosed and undertreated fields in conventional care.

The right to optimal hormonal levels asserts that every person has the right to access the tests and treatments necessary to maintain or restore functional hormonal levels — based on their individual physiology, not on statistical population averages that systematically fail those at the extremes of the distribution.

Thyroid hormones

Hypothyroidism is among the most underdiagnosed conditions in medicine. Conventional diagnosis relies almost exclusively on TSH — a pituitary signal, not a direct measure of thyroid hormone activity in tissues. Millions of people with symptoms of hypothyroidism (fatigue, weight gain, cold intolerance, depression, cognitive slowing, hair loss) are told their “thyroid is normal” on the basis of a TSH within population ranges, while their free T3 (the metabolically active hormone) remains suboptimal.

The right to thyroid care includes:

• Access to complete testing: TSH, free T4, free T3, reverse T3, thyroid antibodies (TPO, anti-Tg)
• Recognition that a “normal” TSH does not exclude functional hypothyroidism if free T3 is low
• Access to T3-containing treatments (such as liothyronine or desiccated thyroid) for patients who do not adequately convert T4 to T3 — a known genetic variation (DIO2 polymorphism) affecting 15–20% of the population
• Treatment of Hashimoto’s thyroiditis as an autoimmune disease, not merely a TSH management problem

Sex hormones

Testosterone deficiency in men — low testosterone affects energy, libido, muscle mass, bone density, mood, and cardiovascular risk. Reference ranges for “normal” testosterone are drawn from mixed populations including elderly men, confounding the clinical interpretation. A man with a testosterone at the bottom of the reference range but symptomatic has a legitimate therapeutic need.

Testosterone in women — female testosterone is rarely measured, yet it is essential to libido, energy, bone density, and muscle function in women. Its decline begins in the thirties and accelerates after menopause. Testosterone is rarely offered to women as part of hormonal care, despite evidence and clinical guidelines in several countries supporting its use.

Oestrogen and progesterone — the perimenopause and menopause transition involves a complex restructuring of the hormonal environment that affects sleep, mood, cardiovascular function, cognitive function, and bone density. The refusal to treat symptomatic women based on population-level risk statistics rather than individual risk assessment violates the principle of individual physiological integrity.

The right to bioidentical hormone therapy — when indicated, individuals have the right to access hormonal treatments in forms that match the body’s natural hormones (bioidentical estradiol, progesterone, testosterone) rather than being limited to synthetic analogues with different risk profiles.

Adrenal hormones and cortisol

Chronic stress produces chronic dysregulation of the hypothalamic-pituitary-adrenal axis. “Adrenal fatigue” — while contested as a clinical diagnosis — describes a real spectrum of HPA axis dysfunction that conventional medicine largely ignores unless it reaches the extreme of Addison’s disease or Cushing’s syndrome. The functional dysregulation between these poles affects a large portion of the chronically stressed population.

Cortisol testing (four-point salivary cortisol, ACTH stimulation test) can identify patterns of dysregulation invisible to a single morning cortisol. The right to adequate adrenal assessment is part of the broader right to understand one’s own hormonal physiology.

Insulin and metabolic hormones

Insulin resistance — the progressive inability of cells to respond to insulin — precedes type 2 diabetes by years to decades. Fasting glucose remains normal while fasting insulin rises. HOMA-IR (a simple calculation from fasting glucose and insulin) captures this pre-diabetic state that standard glucose testing misses entirely. The right to early detection of insulin resistance, before irreversible beta-cell damage occurs, is a fundamental aspect of metabolic hormonal rights.

The principle of individual physiology

Reference ranges in hormonal medicine are derived from population distributions, not from functional physiological targets. What is statistically “normal” for a population may be biologically inadequate for a given individual. The right to optimal hormonal levels insists that treatment decisions be based on the individual’s symptoms and functional physiology — not on whether their number falls within an arbitrarily defined population band.